Results 131 to 140 of about 48,845 (222)
Introduction: In this paper, we report a case of visual impairment during treatment with sunitinib in a patient with metastatic renal cell carcinoma. Methods: Retrospective chart review was used.
Mechteld C.S. van Olden +5 more
doaj +1 more source
Sunitinib specifically augments glucose-induced insulin secretion
The tyrosine kinase inhibitor sunitinib is used for the treatment of numerous cancers in humans. In diabetic patients, sunitinib lowers blood glucose levels and improves glycaemic control.
Lutz, S.Z. +11 more
core +1 more source
ABSTRACT Background Proton pump inhibitors (PPIs) raise stomach pH, leading to reduced bioavailability of many tyrosine kinase inhibitors (TKIs), thereby affecting treatment outcomes. To what extent this interaction occurs in clinical practice remains underexplored.
Grietje van Elp +5 more
wiley +1 more source
ABSTRACT Brain metastases (BMs) represent a major clinical challenge due to their high incidence in cancers such as non‐small cell lung cancer (NSCLC) and breast cancer, and the limited efficacy of systemic therapies resulting from inadequate drug penetration across the blood–brain barrier.
Yuqian Zhao, Weize Huang
wiley +1 more source
Abstract Management of Zollinger–Ellison syndrome (ZES) in patients with multiple endocrine neoplasia type 1 (MEN1) remains controversial, particularly in non‐metastatic disease where the role of surgery is debated. In contrast, treatment of metastatic disease is guided by established systemic approaches.
Kosmas Daskalakis +27 more
wiley +1 more source
Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley +1 more source
Spatial transcriptomics tumor microenvironment determinants of tyrosine kinase inhibitor response in renal cell carcinoma: results from a phase 2 clinical trial. [PDF]
Hasanov E +14 more
europepmc +1 more source
Cell Village Captures Populational Heterogeneity of Sunitinib Cardiotoxicity. [PDF]
Kojic A +10 more
europepmc +1 more source
Converting lysosomes into photothermal organelles enables nanoparticle-free tumor ablation via intracellular vapor bubbles. [PDF]
Lu T +17 more
europepmc +1 more source
Immunogenic cell death as a mechanism of synergy between sunitinib and <sup>177</sup>Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors. [PDF]
Essler M +4 more
europepmc +1 more source

